Patents Assigned to Cardiawave
  • Patent number: 12605569
    Abstract: A method for testing the accuracy and the performance of an ultrasound transducer able to generate cavitation bubbles by placing in a volume of an ultrasound-transmitting medium an elastomer block at an expected cavitation region of the ultrasound transducer, activating the ultrasound transducer so as to generate cavitation bubbles in the elastomer block, detecting in the elastomer marks corresponding to the generated cavitation bubbles and deducing from the marks the three-dimensional characteristics of a real cavitation region of the ultrasound transducer. A system comprising volume of an ultrasound-transmitting medium, an elastomer block disposed in the volume of an ultrasound-transmitting medium, and an ultrasound transducer is also provided.
    Type: Grant
    Filed: October 22, 2021
    Date of Patent: April 21, 2026
    Assignee: CARDIAWAVE
    Inventors: Robin Penot, Daniel Suarez, Mathieu Remond, Wojciech Kwiecinski
  • Patent number: 11633199
    Abstract: An apparatus for treating vascular thrombosis with ultrasound, includes a therapeutic ultrasonic transducer, suitable for generating focused ultrasonic waves that propagate along an emission axis; an imaging ultrasonic transducer associated with the therapeutic transducer; a means for moving the focal spot of the therapeutic ultrasonic transducer along the emission axis with respect to the imaging transducer; a motorized mechanical system for translating the transducers along at least a first axis parallel to the emission axis and a second axis perpendicular to the first; and an electronic control system for driving the motorized mechanical system and the means for moving the focal spot of the therapeutic transducer.
    Type: Grant
    Filed: October 18, 2018
    Date of Patent: April 25, 2023
    Assignee: CARDIAWAVE
    Inventors: Guillaume Goudot, Mathieu Pernot, Mickael Tanter, Michael Vion
  • Patent number: 11554386
    Abstract: An ultrasound imaging and therapy device includes an array of concentric annular ultrasound transducers, and an ultrasound imaging device situated inside an innermost transducer of the plurality of concentric annular ultrasound transducers, wherein it further comprises a mechanical linkage allowing a tilting movement of the array of concentric annular ultrasound transducers with respect to the ultrasound imaging device and in that the ultrasound imaging device protrudes in an axial direction from the array of concentric annular ultrasound transducers; whereby the ultrasound imaging device can be kept stationary and in direct or indirect contact with a patient's skin while the array of concentric annular ultrasound transducers is tilted so as to move a focal point of ultrasound waves generated by the concentric annular ultrasound transducers within an imaging region of the ultrasound imaging device.
    Type: Grant
    Filed: April 21, 2017
    Date of Patent: January 17, 2023
    Assignees: CARDIAWAVE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
    Inventors: Mathieu Pernot, Michael Vion, Mickael Tanter
  • Patent number: 10736603
    Abstract: An apparatus for treating or preventing a valvular disease comprises: a ultrasound probe located externally to a heart of patient, able to produce ultrasound waves focused inside the heart and suitable to generate, at a focal spot, a pressure sufficient to result in cavitation, an imaging device for mapping in real time a treatment region of a cardiac valve of the patient, the treatment region comprising at least one leaflet of the cardiac valve, a controller configured for driving the ultrasound probe to emit a sequence of focused ultrasound waves, the controller being further configured for steering the focused ultrasound waves so as to scan the entire treatment region to soften the tissues of the treatment region. A method for treating or preventing valvular disease, carried out using the apparatus is also provided.
    Type: Grant
    Filed: April 1, 2016
    Date of Patent: August 11, 2020
    Assignee: CARDIAWAVE
    Inventors: Emmanuel Messas, Mathieu Pernot, Mickael Tanter, Olivier Villemain
  • Publication number: 20180236271
    Abstract: A method and system for secure ultrasound treatment of living tissues using an ultrasound probe comprising a reflective cavity in acoustic communication with living tissues, a transducer to emit an ultrasound wave in the reflective cavity and a transducer to acquire a backscattered signal in the reflective cavity. The method comprises the steps of a) emitting a first ultrasound wave in the reflective cavity that generates a backscattered ultrasound wave in the reflective cavity, b) acquiring a backscattered signal in the reflective cavity, c) determining whether an insonification can be safely performed by computing a similarity value between the backscattered signal and a predefined reference signal, and d) if an insonification can be safely performed, treating the living tissues with a second ultrasound wave emitted in the reflective cavity.
    Type: Application
    Filed: February 19, 2018
    Publication date: August 23, 2018
    Applicants: Cardiawave, Ecole Supérieure de Physique et de Chimie Industrielles de la Ville de Paris, INSERM (Institut National de la Santé et de la Recherche Médicale), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS -, Université Paris Diderot - Paris 7
    Inventors: Mickaël Tanter, Mathieu Pernot, Justine Robin